PMCB · PharmaCyte Biotech, Inc. · Analyst Estimates
$0.36
+0.01 (+1.97%)
At close · Oct 27
Return incl. dividend (before tax)
Going-concern doubt
— cleared Sep 14, 2026
The latest filing no longer states the doubt (first flagged Jul 29, 2026).
View the 10-Q filed Sep 14, 2026Market Cap
$3.76M
Shares
10.74M
Volume · Oct 27
47.71K
Avg daily vol (3M)
195.78K
Analyst Estimates
Compare analyst forecasts for PharmaCyte Biotech, Inc. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Compiled consensus
These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.
Captured 2026-09-18 21:45 UTC · Publication dates shown per estimate · 2 metric / period groups
FY ending 2023-04-30
| Metric | Low | Average | High | Analyst count |
|---|---|---|---|---|
|
Revenue
Publication date not stated |
0.00
|
0.00
|
0.00
|
0
|
Q ending 2022-10-31
| Metric | Low | Average | High | Analyst count |
|---|---|---|---|---|
|
Revenue
Publication date not stated |
0.00
|
0.00
|
0.00
|
0
|